30 Kidney Cancer Journal
there. The full set of recommendations set a new
benchmark for guidelines in this setting. As is the case
with all Consensus Statements, an update will follow
eventually, but for now, this is the gold standard.
Reference
The Society for Immunotherapy of Cancer consensus statement on
immunotherapy for the treatment of advanced renal cell carcinoma
(RCC). Rini BI, Battle D, Figlin RA, et al. Imuno Ther Can. 2019;7:
Article number 354.
Robert A. Figlin, MD
Editor-in-Chief
EDITOR’S MEMO
(continued from inside front cover)
Immunotherapy treatment algorithm for patients with advanced renal cell carcinoma